• Better life with AmoyDx
    more
  • Better life with AmoyDx
    more
  • AmoyDx won the Second Prize of National Scientific and Technological Progress Award
    more
  • Better life with AmoyDx
    more
Scroll

ABOUT AMOYDX

Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kits, which were firstly approved by CFDA and CE certified. 

more
Better Life with AmoyDx

Latest News

Latest News more
19 /Aug

Investigators Present Significant Research During WCLC 2022

Several key researches supported by Amoy Diagnostics were presented at WCLC 2022. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from mor

17 /Aug

AmoyDx® Master Panel--Study Reveals Clinically Relevant Intertumoral Heterogeneity of NSCLCs Driven by MET Exon 14 Skipping Mutation

Vienna – Aug. 7th, 2022. – A study presented at the IASLC World Conference on Lung Cancer 2022 in Vienna disclosed the clinically relevant intertumoral heterogeneity of non-small cell lung cancer (NSCLC) driven by MET exon 14 skipping (METex14 skipping).

17 /Aug

Amoy Diagnostics and Roche Pharma China Jointly Announce Strategic Partnership

The 2nd Roche Pan-Tumor Precision Medicine Innovation Forum was officially held at the Shanghai Roche Pharmaceuticals Campus, where participants had discussions on recent progresses in this field.

09 /Aug

MHLW Approves AmoyDx® Pan Lung Cancer PCR Panel as Companion Diagnostic for Rozlytrek® (Entrectinib) in Japan

TOKYO and XIAMEN, August 9, 2022 -- Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and Precision Medicine Asia Co., Ltd. (“PREMIA”) today announced that the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) had been approved by t

more

New Products

new product release

    New Products

    new product release
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

      NGS

    • HANDLE Classic NGS Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

      NGS

    • HANDLE Classic NGS Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

      NGS

    • HANDLE Classic NGS Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04
    • Pan Lung Cancer PCR Panel

    • HRD Focus Panel

      NGS

    • HANDLE Classic NGS Panel

    • BRCA Pro Panel

    • PLC Pan Lung Cancer PCR Panel
      01
    • HRD HRD Focus Panel
      02
    • Classic HANDLE Classic NGS Panel
      03
    • BRCA Pro BRCA Pro Panel
      04
    1. 01
    2. 02
    3. 03
    4. 04
  1. NGS
  2. PCR
  3. FISH
  4. Extraction

ESMO Asia

https://www.esmo.org/meetings/esmo-asia-congress-2022

December 2-4, 2022
meet us

AMP

https://www.amp.org/events/amp-events-calendar/calendar/amp-2022-annual-meeting-expo/

November 3-5, 2022
Inquiry
* Required information
Manage your account info
Change your password